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Abstract: Reporter genes are useful scientific tools for analyzing promoter 
activity, transfection efficiency, and cell migration. The current study has 
validated the use of tyrosinase (involved in melanin production) as a dual 
reporter gene for magnetic resonance and photoacoustic imaging. MCF-7 
cells expressing tyrosinase appear brown due to melanin. Magnetic 
resonance imaging of tyrosinase-expressing MCF-7 cells in 300 μL plastic 
tubes displayed a 34 to 40% reduction in T1 compared to normal MCF-7 
cells when cells were incubated with 250 μM ferric citrate. Photoacoustic 
imaging of tyrosinase-expressing MCF-7  cells  in  700  μm  plastic  tubes 
displayed a 20 to 57-fold increase in photoacoustic signal compared to 
normal MCF-7 cells. The photoacoustic signal from tyrosinase-expressing 
MCF-7 cells was significantly greater than blood at 650 nm, suggesting that 
tyrosinase-expressing cells can be differentiated from the vasculature with 
in vivo photoacoustic imaging. The imaging results suggest that tyrosinase is 
a useful reporter gene for both magnetic resonance and photoacoustic 
imaging. 
©2011 Optical Society of America 
OCIS codes: (170.5120) Photoacoustic imaging; (170.3880) Medical and biological imaging; 
(170.2655) Functional monitoring and imaging; (000.1430) Biology and medicine. 
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1. Introduction 
Reporter genes are useful tools allowing identification of specific cells within a population of 
cells.  Green  fluorescent  protein  (GFP)  is  a  commonly  used  reporter  gene  that  allows 
identification of transfected cells as well as subcellular localization of proteins when GFP is 
tagged to proteins of interest [1]. In vivo applications are challenged by strong light-scattering 
and poor penetration in tissue. Luciferase is another commonly used reporter gene that can be 
used in vivo although the light produced by most luciferases have a relatively short 
wavelength (<600 nm) causing poor tissue penetration and significant scattering [2]. 
Tyrosinase (TYR) is the key enzyme regulating melanin production in hair and skin in 
humans [3]. Although melanin displays maximal optical absorption at ultraviolet wavelengths, 
melanin has a broad spectrum of optical absorption with significant absorption at some near 
infrared wavelengths which have strong tissue penetrating properties [4]. TYR has previously 
been shown to be a reporter gene for magnetic resonance imaging (MRI) due to the binding of 
melanin with heavy metals which can provide contrast in MRI [5,6]. The current study tests 
whether TYR is also a reporter gene for photoacoustic imaging since melanomas which 
produce melanin can easily be detected with photoacoustic imaging [7–10]. 
Photoacoustic imaging involves exposing a sample with a pulsed laser and detection of the 
emitted ultrasound produced by the thermo-elastic expansion caused by the absorption of the 
laser light in the sample. Combining light delivery and ultrasound detection in one imaging 
modality allows imaging with ultrasonic resolution and is not limited by optical scattering 
[11]. LacZ, encoding the lactose metabolizing enzyme β-galactosidase, has previously been 
demonstrated as a reporter gene for photoacoustic imaging although imaging LacZ expression 
requires the injection of X-gal in a subject [12–14]. X-gal  can  occasionally  cause  skin 
irritation and was not efficiently metabolized in tumors when X-gal was injected systemically 
through the tail vein of rats [12]. TYR as a photoacoustic reporter gene does not require co-
administration of an enzymatic substrate and, in theory, should produce a very strong 
photoacoustic signal since each molecule of expressed TYR will aid in the production of 
multiple melanin molecules each involved in producing a photoacoustic signal. 
2. Methods 
2.1 Cell culture 
MCF-7 Tet-On
® cells (also called MCF-7–TYR in this manuscript), which stably expresses 
the reverse tetracycline-controlled transactivator (rtTA), were purchased from Clontech 
Laboratories,  Inc.  (Mountain  View,  CA).  MCF-7 cells were maintained in Dulbecco’s 
modified Eagle’s growth medium with 10% fetal bovine serum and 200 μg/mL G-418 (A.G. 
Scientific Inc, San Diego, CA). 
For MRI and photoacoustic imaging experiments, T-150 cm
2 tissue culture flasks were 
inoculated with approximately 3.5 x 10
6  cells.  The  next  day,  flasks  had  growth  medium 
replaced with medium that may have contained 1 μg/mL doxycycline (Dox) and/or 250 μM 
ferric citrate (only for MRI experiments). Three days after the medium change, cells were 
washed once with phosphate buffered saline (PBS), trypsinized from the flasks, and 10 mL 
growth  medium  was  added  to  each  flask  to  inhibit  trypsin.  Cells  were  centrifuged  at 
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7 cells 
were centrifuged in 300 μL tubes and PBS above pelleted cells was removed before imaging. 
For photoacoustic experiments, cells were resuspended at 10
8  cells/mL  in  PBS  and  cell 
suspensions were injected in 700 µm transparent plastic tubes which were used for imaging. 
2.2 Generation of MCF-7 cells stably expressing TYR 
cDNA encoding human TYR (accession number NM_000372.1) was purchased from 
Genecopoeia, Inc. (Rockville, MD) in the pReceiver-M02 vector. This vector was used in a 
polymerase chain reaction (PCR) with primers flanking the TYR open reading frame with 
KpnI and NotI restriction enzyme sequences within the 5′ and 3′ primers, respectively. The 
PCR  reaction  yielded  primarily  one  DNA  species  at  approximately  1.7  Kbp  which  was 
agarose-gel purified using a Qiagen Gel Extraction kit (Qiagen, Mississauga, Ontario). The 
purified TYR encoding insert cDNA and the pTRE-Tight inducible expression vector (2.6 
Kbp; Clontech Laboratories, Inc, Mountain View, CA), were both digested with KpnI and 
NotI restriction enzymes (Invitrogen, Carlsbad, CA). Cut vector and insert were ligated 
together  with T4 DNA  ligase (New England Biolabs, Pickering, Ontario) and the ligation 
mixture  was  used  to  transform  Fusion  Blue  competent  cells  (Clontech  Laboratories,  Inc, 
Mountain View,  CA)  which  were plated on  Lysogeny broth plates supplemented  with 50 
μg/mL ampicillin. Bacterial colonies were isolated and plasmid DNA of approximately 4.3 
Kbp was isolated from the resulting colonies. This DNA was co-transfected with DNA 
containing  a  hygromycin  resistance  marker  in  MCF-7 Tet-On
®  cells  using  Lipofectamine 
2000 (Invitrogen, Carlsbad, CA). One day after transfection, cells were trypsinized and 
transferred to 10 cm
2 plates. The next day plates had a medium change containing DMEM 
with 10% FBS, 200 μg/mL G-418, and 300 μg/mL hygromycin. Cells in plates were grown 
for several weeks until large cell colonies were visible. Colonies were individually trypsinized 
from the plates using cloning disks (Invitrogen, Carlsbad, CA) and each colony was tested for 
the ability to produce TYR in the presence of Dox by light microscopy. One colony producing 
brown cells in the presence of 1 μg/mL Dox was designated MCF-7 + TYR cells and these 
cells were used for subsequent experiments (see Fig. 1). 
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rTetR
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TREMOD CMVminΔ TYR
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rTetR
rTetR
 
Fig. 1. Tet-On
®  inducible system for TYR expression. The pTRE-Tight vector contains a 
promoter composed of the minimal cytomegalovirus (CMV) promoter as well as a modified 
tetracycline responsive element (TREMOD). The tetracycline-responsive transactivator (rTetR), 
containing three minimal transcription activation domains from the Herpes Simplex Virus 
VP16 protein, will only bind to the TREMOD sequence and induce expression of TYR in the 
presence of Doxycycline (Dox). 
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The vials of cells as prepared above were imaged on a 9.4 Tesla animal MR imaging system 
(Magnex Scientific, Oxford, UK). This is a horizontal bore unit with an inner bore diameter of 
12.0 cm, and a 200 mT/m gradient set. All radio frequency (RF) transmission and reception 
for image acquisition was performed by a 44 mm inner diameter birdcage coil. The unit is 
controlled by a TMX console (National Research Council of Canada Institute for 
Biodiagnostics—West, Calgary, AB, Canada). 
The vials in groups of four were oriented vertically and clustered in a square array at the 
most sensitive region of the RF coil. With the samples present, the coil was tuned and 
matched at 400 MHz and was then positioned at the magnet isocentre. Calibration of a 90 
degree pulse was accomplished by maximizing the signal resulting from a one-pulse 
experiment (utilizing the same selective RF pulse to be used in subsequent imaging) with a 
lengthy 8 second repetition time (TR). The RF magnetic field within the birdcage coil (B1) 
was mapped to ensure uniformity within the region of interest. A double-angle technique [15] 
was utilized for this purpose, revealing a B1 field with less than 5 percent deviations from 
uniformity over the vials. The quantification of T1 in this work was accomplished through a 
method similar to that used by Ponce et al. [16] Images were acquired using a single-slice 
spoiled gradient-echo sequence with a TR of 250 ms, and a TE at 5 ms. The fields-of-view for 
these images were 20 by 20 mm encoded over a 128 by 128 matrix, yielding pixels with 
dimensions of 0.16 mm. The coronal image had a slice thickness of 1.0 mm and cut a cross-
section mid-way through the cell populations in the vials. Multiple versions of these images 
were acquired over a series of flip-angles ranging between 5 and 90 degrees in 5 degree 
increments. 
2.4 MR image analysis 
Images were exported offline and processed using Matlab for T1 quantification. The signal 
variation pattern seen over each pixel as the flip angle was changed was fitted with a non-
linear unconstrained optimization scheme (Matlab’s fminsearch function) to the analytic 
function below: 
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where θ was the flip angle and S0 was the maximum signal available. With the flip angles and 
the TR known, the only variables to be assigned by the optimization were T1 and S0. In this 
way, a pixel-by-pixel T1 time was calculated over all the vials. 
2.5 Photoacoustic imaging system 
A 25 MHz ultrasound transducer (V324-SM, Panametrics, Waltham, MA, USA), with a focal 
length of 12.7 mm and a −6 dB fractional bandwidth of approximately 50%, was mounted 
onto a motor controller to obtain interlaced ultrasound-photoacoustic B-scans images. The 
transducer was connected to a pulser-receiver  unit  (Olympus  Panametrics-NDT Model 
5073PR) which excited the transducer and amplified received signals by 39 dB. Photoacoustic 
signals were generated by an Optical Parametric Oscillator (OPO; Continuum, Surelite OPO 
Plus) pumped by a 10 Hz, 532 nm, Q-switched laser (Continuum Surelite, SLIII-10). The 
OPO produced tunable-wavelength 8-ns pulses range from 410 to 710 nm. The laser pulse 
was steered around the ultrasound transducer by a conical mirror custom light-delivery optics 
and focused at a point 12.7 mm below the transducer using a previously described setup [17]. 
The system provided a photoacoustic lateral spatial resolution of 180 μm, while the axial 
spatial resolution was ~40 μm. A digital input/output card (National Instruments, NI CB/SCB-
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ultrasound and photoacoustic imaging. The voltage levels were digitized by a 125 
megasample/s  data  acquisition  card  (Gage,  CompuScope  8289)  with  12-bit accuracy and 
stored for post-processing by Matlab software. A photodiode measured the amount of light 
from each laser pulse and was used to normalize the photoacoustic signals to account for laser 
pulse-to-pulse instability. At all wavelengths used, the laser fluence at the ultrasound focal 
location, measured in air was <20 mJ/cm
2. The actual fluence reaching the targets will be 
much less in a scattering medium. 
2.6 Photoacoustic imaging protocol 
Five 700-µm (inner-diameter) transparent plastic tubes were aligned on an acrylic frame. One 
of the tubes was loaded with whole rat blood (blood was taken from the rat and placed in a 10 
ml BD Vacutainer containing 143 USP units of sodium  heparin). The remaining four test 
tubes were loaded with one of the four combinations of ± Dox and MCF-7 ± TYR cells in 
PBS, hereby named −/−, -/+, +/−, +/+ tubes ( ± Dox/MCF-7 ± TYR), where + represents the 
presence of either Dox or MCF-7 + TYR cells and - represents the absence of either Dox or 
MCF-7–TYR cells. The tubes were submerged in water with or without Intralipid to mimic 
optical scattering which is present in biological tissue. Using a voice-coil actuator and motor 
controller to laterally move the ultrasound transducer at a rate of 0.5 mm/s, a one-to-one, 
interlaced ultrasound-photoacoustic  B-scan image was formed of all five test tubes. 
Ultrasound imaging was used to determine the position of the tubes and ensure only 
photoacoustic signals within the plastic tubes were analyzed. The speed of sound was assumed 
to be constant throughout the ultrasound propagation at approximately 1500 m/s. The motor 
position was reset before each B-scan was initiated. Five B-scan images were taken at five 
points,  spaced  1  mm  apart,  along  the  tubes.  The  B-scan  image  sets  were  taken  for  four 
different wavelengths; 576 nm, 594 nm, 604 nm, and 650 nm. Finally, the experiment was 
repeated for several Intralipid (Intralipid 20%, Fresenius Kabi, Uppsala, Sweden) 
concentrations which correspond to a reduced scattering coefficient (µs
’) of 0 (in pure water), 
through 3.10 cm
−1 at a depth of 12.7 mm. The reduced scattering coefficient of the intralipid 
stock-solution was measured independently via an oblique-incidence-diffuse-reflectance 
technique using a 532-nm continuous-wave diode laser. The methodology used for measuring 
the reduced scattering coefficient of the Intralipid stock demonstrated accurate results (R
2 = 
0.99) in a previous study [18]. Since the imaging depth of high-resolution photoacoustic 
microscopy is typically 2-3 mm, light penetration over the ultrasonic focal distance of 12.7 
mm in a solution with µs
’ = 1.7 cm
−1 (the value used for Fig. 5 below) is roughly equivalent to 
light penetration over ~2.2 mm in a µs
’  = 10 cm
−1  turbid medium. Hence experimental 
conditions are designed to mimic typical penetration distances in biological tissues. For the 
highest µs
’ examined, penetration in a µs
’ = 10 cm
−1 turbid medium would be equivalent to ~4 
mm. 
2.7 Photoacoustic image analysis 
Signal levels were assessed by examining the maximum signal generated within each tube 
(tube lumen positions determined by ultrasound images) and the average absolute signal 
within a 5 by 7 pixel area (0.25 mm laterally by 0.11 mm depth). The maximum and average 
signals  were  averaged  over  all  five  B-scan images and recorded along with the standard 
deviation. Combined ultrasound-photoacoustic B-scan images were formed by first separating 
the two signals, adjusting the depth of the photoacoustic signal, and combining them by 
thresholding the photoacoustic signal. The threshold level was adjusted manually for best 
visual contrast while still maintaining  the  form  of  the  raw  B-scan image. Further image 
processing was used to smooth the image, by interpolating the image so that its size 
quadrupled in both dimensions, and series of median filters were used to remove large 
amplitude noise artifacts. Depending on the signal to noise ratio, a sequence of either one or 
three median filters was used. For the images with tubes submerged in pure water, a single 
#139902 - $15.00 USD Received 20 Dec 2010; revised 25 Feb 2011; accepted 1 Mar 2011; published 2 Mar 2011
(C) 2011 OSA 1 April 2011 / Vol. 2,  No. 4 / BIOMEDICAL OPTICS EXPRESS  775median filter with dimensions of [3x3] was used to eliminate the speckle. Only one median 
filter was chosen  in  these  cases  because  abnormal  spikes  in  noise  were  still  negligible 
compared to the signal generate from the TYR+/Dox + and blood tubes. For images with 
tubes submerged in water containing intralipid, a series of three median filters were used, with 
each subsequent median filter using a larger area (square matrix of 3, then 5, then 7). This was 
necessary because the signal from the tubes was only slightly greater (although consistently 
greater) than abnormal spikes in noise and the resulting image contrast was worsened because 
of speckle. Statistical differences between signals from different samples were determined 
using two-tailed student t-tests. 
3. Melanin expression in MCF-7 cells 
MCF-7–TYR and MCF-7 + TYR cells were inoculated in T-25 cm
2 flasks containing growth 
medium with or without 1 μg/mL Dox. After three days of cell growth, flasks were imaged 
with an Olympus IX70 microscope (200× magnification) to visualize melanin expression (Fig. 
2). Only MCF-7 + TYR cells incubated with Dox contained melanin which appeared as a dark 
brown pigment in the cells, suggesting that TYR expression was inducible with Dox. 
 
Fig. 2. Microscopic analysis of TYR expression in MCF-7 cells. MCF-7-TYR (a + b) and 
MCF-7 + TYR cells (c + d) were incubated in growth medium with (b + d) or without (a + c) 1 
μg/mL Dox. MCF-7 + TYR cells incubated with DOX appear dark brown due to melanin 
production. Scale bars represent 100 μm lengths. 
4. MR imaging of melanin-producing cells 
A T1 map and a corresponding T1-weighted image of a four-vial cell group are displayed in 
Fig. 3. The mean T1  times of the vials in msec, starting with the top right and moving 
clockwise are 756 +/− 50 (MCF-7 + TYR, + Dox), 1243 +/− 96 (MCF-7 + TYR, -Dox), 1269 
+/− 128 (MCF-7-TYR,-Dox), and 1146 +/− 89 (MCF-7-TYR + Dox). This represents a 34 to 
40 percent reduction in T1 when cells are capable of producing TYR in the presence of Dox. 
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Fig. 3. (a) MR T1-map with intensity values given in milliseconds. Each of the four vials has a 
different combination of positive or negative TYR expression (MCF-7 ± TYR) and positive or 
negative Dox presence (+/−Dox). (b) T1-weighted image with a flip angle of 90 degrees and a 
TR of 250 ms. 
5. Photoacoustic imaging of melanin-producing cells 
B-scan images show tubes containing, from left to right, −/−, +/−, -/+, +/+, ( ± Dox/MCF-7 ± 
TYR) and blood. The photoacoustic signal from the −/−, +/−, and -/+ tubes were negligible in 
all images – any signal from the tube primarily originated from the tube walls – 50 mV. In 
water, µs
’ of 0 cm
−1, the signal from these tubes at all wavelengths were less than 60 mV and 
were generally 5-10 times lower than the signal from either blood (p < 0.0005) and TYR (p < 
0.003). For wavelengths around 576 nm the blood demonstrated a much more intense signal 
than the +/+ tubes (2.1-fold greater; p < 0.003), while at 650 nm the blood demonstrated a 
much smaller signal intensity than the +/+ tubes (2.2-fold smaller; p < 0.02). Image quality 
decreased rapidly as the amount of Intralipid increased; however, signal levels from both the 
blood and +/+ tubes consistently demonstrated higher intensities compared with −/−, +/−, and 
-/+. The characteristic shape provided in Fig. 4 is consistent for µs
’ of up to 2.5 cm
−1 at a depth 
of  12.5  cm;  however,  signal  intensities  decrease.  Finally,  the  image  processing  described 
above showed that the photoacoustic signal from blood was much greater than the +/+ tube at 
576 nm while the signal from blood was small compared with +/+ tube at 650 nm (Fig. 5). 
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Fig. 4. Photoacoustic signal intensities of the five test tubes. The -\-, -\ + , and + \- test tubes 
have negligible signal compared to the + \ + and blood (−/− = -Dox/MCF-7-TYR). 
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Fig. 5. Combined ultrasound (grayscale) and photoacoustic (orange colormap) B-scans of tubes 
containing our test samples. White circles are manually drawn to further demarcate tube 
locations. From left to right the tubes are −/−, +/−, -/+, +/+, and blood (−/− = -Dox/MCF-7-
TYR). Only the cells in the +/+ tube expressed melanin. (a) B-scan image at a wavelength of 
576 nm. A threshold of 50% was used. Blood is seen best at this wavelength. (b) B-scan image 
at a wavelength of 650 nm in the same turbid medium as (a). A threshold of 50% maximum 
signal was used. Compared to the other samples, the melanin-expressing cells displayed the 
highest photoacoustic signal at 650 nm. 
We can estimate the sensitivity of our system by accounting for cell settling and the 
resolution of our ultrasound transducer. Figure 5 demonstrates that the + Dox/+TYR cells 
settled away from the top of the tube, presenting signal approximately 150 μm below the top 
of the tube. Therefore, cells were present in approximately 77% of the tube and a correction 
factor of 1.3 is needed to calculate the concentration of the settled cells. The volume of cells 
contributing to signal can be calculated using the lateral and axial resolutions of the transducer 
– 180 μm and 40 μm, respectively [17]. Hence, the number of cells detected in each voxel is 
approximately 169 cells. Finally, we can find the number of cells to provide unity SNR by 
dividing by the SNR – calculated using the average signal in a 5x7 (lateral by axial) area 
around the maximum divided by the standard deviation of the noise calculated using a 20x20 
area below any signals generated by the tubes. Cells in media with reduced scattering 
coefficients of 0, 1, and 2.5 cm
−1 at a depth of 12 mm demonstrated an average SNR of 158.5, 
5.99, and 3.66 V/V, respectively. Table 1 summarizes the number of cells needed for unity 
SNR (V/V) for each of the four wavelengths used in this study. 
Table 1. Number of Cells for unity SNR (V/V) 
Reduced Scattering Coefficient,  Wavelength 
μs′  576 nm  594 nm  604 nm  650 nm 
0 cm
−1  0.93 ± 0.31  1.06 ± 0.36  1.58 ± 0.55  1.27 ± 0.43 
1 cm
−1  34.1 ± 11.7  30.6 ± 10.6  36.2 ± 9.22  24.0 ± 7.13 
2.5 cm
−1  44.4 ± 3.41  43.8 ± 8.34  56.6 ± 10.9  46.5 ± 10.7 
6. Discussion and conclusions 
The use of TYR expression creates a substantial decrease in T1 that can be exploited as a 
contrast mechanism in MRI. For example, considering the reduction of T1 from 
approximately 1200 ms to 756 ms as determined experimentally above, a TR setting of 80 ms 
in conjunction  with a 68 degree  flip angle  will  yield a  100% increase in signal over the 
background. This signal boost is considerably greater than that noted by Weissleder et al. [6], 
where a 29 percent signal increase was seen. However, the previous study was conducted at a 
much lower field strength (1.5 T), and the sequence timings they used may or may not have 
been fully optimized for contrast visualization. Further, the signal boost may be affected by 
#139902 - $15.00 USD Received 20 Dec 2010; revised 25 Feb 2011; accepted 1 Mar 2011; published 2 Mar 2011
(C) 2011 OSA 1 April 2011 / Vol. 2,  No. 4 / BIOMEDICAL OPTICS EXPRESS  778other factors including the magnitude of TYR expression and concentration of iron available 
to be scavenged by melanin. 
For the photoacoustic imaging studies, ultrasound was used to co-register the tube 
locations to ensure photoacoustic signal analysis is appropriately localized to the tubes of 
interest. In the ultrasound and photoacoustic images, only the top and bottom of the tube outer 
and inner walls are seen. This is because ultrasound reflected from the side of the tube will be 
deflected away from the receive-direction of the ultrasound transducer. Additionally, the 
ultrasound transducer has a band-pass response, and hence emphasizes only edges (changes of 
acoustic impedance) along the line-of-sight of the transducer. A similar effect is seen in the 
photoacoustic images: signals are strongest from the top of the cells, while some signal is also 
seen from the bottom. While light scattering partially illuminates the tube from all directions 
the ultrasound transducer acts as a bandpass filter along the depth-direction, emphasizing 
absorption edges. In the case of the melanin-expressing cells, signal is most likely seen from 
the middle of the tube because cells have settled within the tube. A transducer with an 
improved low-frequency response could be used to visualize the internal structure rather than 
just the top and bottom of the cell suspension. 
Although the minimum absorbance of blood is around 680 nm, we chose to examine the 
photoacoustic contrast between blood and TYR expressing MCF-7 cells at 650 nm because 
the stability and waveform of the laser pulse was much better. The 576 nm wavelength was 
chosen to maximize the signal of the blood. The signal for blood rapidly decays while the 
signal for the TYR expressing MCF-7 cells demonstrated relatively constant signal 
amplitudes. There is actually signal from the blood tube in Fig. 5(b), however, we chose a 
threshold value above this signal level as one way to see only gene expression in the + 
Tyr/+Dox tube. By examining multiple wavelengths at the same time, one can potentially 
perform multi-wavelength image analysis to suppress the signal from the blood and enhance 
the signals from melanin-producing cells from images taken in vivo. 
TYR expression in MCF-7 cells caused a significantly larger increase in photoacoustic 
signal (>20-fold) compared to MRI signal (up to 2-fold), suggesting TYR is a stronger 
reporter gene for photoacoustic imaging compared to MRI. When using TYR as a reporter 
gene for photoacoustic imaging, no additional contrast agent is necessary while for MRI, a 
heavy metal such as iron is needed for increased signal. However, the photoacoustic 
microscopy system we use presently has limited imaging depths while MRI does not, 
suggesting that MRI may be more appropriate when using TYR as a reporter gene in deep 
tissues. Future work will investigate photoacoustic imaging using lower-frequency transducers 
and near-infrared, rather than far-red light, for improved depth-penetration. Additionally, 
ongoing work aims to show deeper imaging of photoacoustic-based gene expression in real-
time.  Presently  photoacoustic  imaging  frame-rates are limited by the 10-Hz laser pulse-
repetition rates and the requirement for one laser-pulse-per photoacoustic A-scan line. 
Our photoacoustic system provides single cell resolution with SNR of ~1 V/V with fluence 
of  ~20  mJ/cm
2  when tubes containing tyrosinase-expressing cells are submerged in pure 
water. When tubes containing tyrosinase-expressing cells are submerged in optical scattering 
media, more cells are required to achieve a SNR of 1 V/V. Based on our results, an estimate 
of the number of cells needed to image in vivo  (μs′  ≈10 cm
−1) at a depth of 3 mm is 
approximately 45 cells. 
Whole body imaging with fluorescent proteins and luciferases as reporter genes has been 
primarily limited to small animals due to significant optical absorption and scattering of the 
emitted signal. The emitted signal of melanin in photoacoustic imaging  is not light but 
acoustic pressure waves which can propagate through tissue to a much greater extent than 
visible light. For this reason, photoacoustic imaging should be capable of greater theoretical 
imaging depth compared to conventional optical and fluorescence imaging. Our preliminary 
results demonstrate that, when using a linear array photoacoustic system, TYR-expressing 
cells can be visualized through 4 cm of chicken tissue (data not shown), suggesting that it may 
be possible to image gene expression at greater imaging depths using TYR and photoacoustic 
imaging compared to conventional optical-based reporter genes. 
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1) levels of TYR expression and melanin production in target cells, 2) total number of TYR-
expressing cells used for imaging, 3) tissue depth of TYR-expressing cells in the animal, 4) 
tissue composition between TYR-expressing cells and transducer (e.g. degree of vasculature, 
presence of gas or bone), and 5) the resolution and tissue penetration capabilities of the 
photoacoustic system used for imaging. Researchers should carefully consider all of these 
factors if using TYR as an in vivo reporter gene for photoacoustic imaging. 
Our experiments are in agreement with previous work that suggests that TYR expression 
exhibits low level toxicity in mammalian cells [6]. TYR expression in MCF-7 cells can cause 
a significant fraction of cells to detach from the tissue culture surface (data not shown). In the 
current study, TYR expression was inducible which allowed the growth of large amounts of 
healthy cells which were induced to express TYR three days before imaging. This inducible 
TYR expression system was useful to minimize TYR toxicity and will likely become crucial 
for future in vivo experiments including MRI and photoacoustic imaging of xenograft tumors 
with or without TYR expression as well as quantitative determination of the sensitivity of 
TYR as a reporter gene for both imaging modalities. Doxycycline is an attractive agent for 
inducing expression in vivo because it can simply be added to the drinking water of animals. 
Such experiments will aid in the development of TYR as a promising reporter gene for MRI 
and photoacoustic imaging which may be useful non-invasive methods for analyzing relative 
transfection rates, tumor growth rates, or cell migration in animals. Furthermore, we hope that 
other absorption-based reporter genes will emerge that will permit sensitive molecular 
imaging studies of gene expression in vivo with high contrast and ultrasonic spatial resolution. 
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